Atrial Flutter Hypertension Pulmonary 
Dr. S. Venkatesan MD
APRIL 28, 2024
Both atria develop from a combination of the primitive atrium, sinus venous, and pulmonary veins.It A fibrillatory wave that occurs at a rate of more than 600 beats per minute can cause fatigue in the long run, leading to atrial dilation. In all probability, this dilation is a form of atrial tachycardia and atrial cardiomyopathy.
Heart BMJ
SEPTEMBER 16, 2024
Initial assessment with electrocardiography revealed a regular narrow complex tachycardia with 2:1 atrioventricular (AV) relationship, no clear isoelectric baseline and positive P waves in lead V1 consistent with an atrial flutter of left atrial origin with a rapid ventricular rate (~160/min) ( figure 1A ).
Dr. Smith's ECG Blog
MARCH 28, 2024
male with pertinent past medical history including Atrial fibrillation, atrial flutter, cardiomyopathy, Pulmonary Embolism, and hypertension presented to the Emergency Department via ambulance for respiratory distress and tachycardia. Bedside ultrasound showed volume depletion and no pulmonary edema.
Dr. Smith's ECG Blog
AUGUST 14, 2023
The bedside echo showed a large RV (Does this mean there is a pulmonary embolism as the etiology?) The rhythm is 2:1 atrial flutter. The flutter waves can conceal or mimic ischemic repolarization findings, but here I don't see any obvious findings of OMI or subendocardial ischemia. Lots of info here.
Dr. Smith's ECG Blog
JUNE 27, 2021
A 50-something man with history only of alcohol abuse and hypertension (not on meds) presented with sudden left chest pain, sharp, radiating down left arm, cramping, that waxes and wanes but never goes completely away. To me, this looks like pulmonary edema. B-line predominance bilateral lungs indicates pulmonary edema.
Dr. Smith's ECG Blog
JANUARY 5, 2020
M Y A NSWER: In my experience, MAT is the 2nd-most commonly overlooked cardiac arrhythmia ( surpassed only by Atrial Flutter ). The KEY to getting this patient better will doubtlessly include optimizing pulmonary function. = Q UESTION : Why is M AT ( M ultifocal A trial T achycardia ) so commonly overlooked? GET a 12-lead!
Journal of Cardiovascular Electrophysiology
DECEMBER 16, 2024
This prospective, multicenter study conducted in the United States, Italy, and China investigated the safety and efficacy of pulmonary vein isolation (PVI) using HELIOSTAR in drug-refractory symptomatic PAF. Central Illustration. The primary safety endpoint was the occurrence of early-onset primary adverse events (PAEs).
Expert insights. Personalized for you.
75 
Let's personalize your content